Medical Advocates

HCV Infection/Disease
  Oncology

General Reports
Hepatocellular  Carcinoma

Lymphoma         
Leiomyosarcoma








 

HCV Main Page Main New/Newsworthy   Home Page    

Last Update:  July 22, 2008
   D
ocuments identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader


General Reports
 

     Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus and malignancy.
Suriawinata A, Thung SN.
Hepatol Res. 2007 Apr 16;
Abstract

Hepatocellular  Carcinoma
 

     Journal Papers, Abstracts, and Commentaries

 
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy
for chronic hepatitis C.

Scherzer TM, Reddy KR, Wrba F, et al
J Viral Hepat. 2008 Jul 10.
Abstract
 
Impact of Diabetes on Recurrence of Hepatocellular Carcinoma after Surgical Treatment in
Patients With Viral Hepatitis.
Komura T, Mizukoshi E, Kita Y, et al  
Am J Gastroenterol.
2007 Jun 15;
Abstract
 
FULL TEXT ARTICLE
Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.
Trinchet JC, Ganne-Carrie N, Nahon P, et al 
World J Gastroenterol.
2007 May 7;13(17):2455-60.
Paper
 
Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon
therapy for chronic hepatitis C.

Suganami F, Tomiyama Y, Ohmoto K, et al 
Nippon Shokakibyo Gakkai Zasshi. 2007 Jun;104(6):809-14.
Abstract
 
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage,
treatment received, and survival.

Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP.
Clin Gastroenterol Hepatol
. 2007 Apr;5(4):508-12.
Abstract
 
\Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma)
in a patient with hepatitis C virus-related cirrhosis.

Inaba K, Suzuki S, Sakaguchi T, et al  
J Hepatobiliary Pancreat Surg. 2007;14(2):204-9.
Abstract
 
The risk of end stage liver disease and hepatocellular carcinoma among persons infected
with hepatitis C virus: publication bias?
Goodgame B, Shaheen NJ, Galanko J, El-Serag HB. 
Am J Gastroenterol. 2003 Nov;98(11):2535-42.
Abstract
 
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with
hepatitis C. A systematic review and critical analysis.

Gupta S, Bent S, Kohlwes J
Ann Intern Med. 2003 Jul 1;139(1):46-50.
Abstract

ole of hepatitis C virus in the development of hepatocellular carcinoma: Transgenic approach to viral hepatocarcinogenesis.
Koike K, Moriya K, Kimura S.
J Gastroenterol Hepatol 2002 Apr;17(4):394-400
Abstract

Transient biochemical response in interferon therapy decreases the development of hepatocellular
carcinoma for five years and improves the long-term survival of chronic hepatitis C patients.
Okanoue T, Itoh Y, Kirishima T, et al
Hepatol Res 2002 May;23(1):62-77
Abstract

 

     Conference Reports, Abstracts, and Posters

  CONFERENCE PRESENTATION
Hepatocellular Carcinoma (HCC) and HCV in the United States
El-Serag HB
[NIH Consensus Development Conference on  Management of Hepatitis C: 2002]
Report
 

Lymphoma
 

General Reports

     Journal Papers, Abstracts, and Commentaries

 
Excellent Prognosis and Prevalence of HCV Infection of Primary Hepatic and Splenic
Non Hodgin's Lymphoma

De Renzo A, Perna F, Persico M, et al
Eur J Haematol.
2008 Apr 4
Abstract
 
Hepatitis C infection and risk of malignant lymphoma.
Schöllkopf C, Smedby KE, Hjalgrim H et al 
Int J Cancer.
2008 Feb 12
Abstract

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.
Kelaidi C, Rollot F, Park S,
Leukemia. 2004 Jul 29
Abstract
 
Role of hepatitis C virus infection in malignant lymphoma in Spain.
de Sanjose S, Nieters A, Goedert JJ, et al
Int J Cancer. 2004 Aug 10;111(1):81-5.
Abstract

Non-Hodgkin's Lymphoma

     Journal Papers, Abstracts, and Commentaries
 

 
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the
International Lymphoma Epidemiology Consortium.
de Sanjose S, Benavente Y, Vajdic CM, et al
Clin Gastroenterol Hepatol. 2008 Apr;6(4):451-8
Abstract
 
Excellent Prognosis and Prevalence of HCV Infection of Primary Hepatic and Splenic
Non Hodgin's Lymphoma

De Renzo A, Perna F, Persico M, et al
Eur J Haematol. 2008 Apr 4
Abstract
 
Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada.
Spinelli JJ, Lai AS, Krajden M, et al
Int J Cancer. 2008 Feb 1;122(3):630-3.
Abstract
 
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with
hepatitis C virus.
Giordano TP, Henderson L, Landgren O, et al
JAMA.
2007 May 9;297(18):2010-7.
Abstract
 
Hepatitis C and risk of lymphoma: results of the European multicenter case-control study
EPILYMPH.

Nieters A, Kallinowski B, Brennan P, et al
Gastroenterology. 2006 Dec;131(6):1879-86.
Abstract
 
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.
Franceschi S, Polesel J, Rickenbach M, et al
Br J Cancer. 2006 Dec 4;95(11):1598-602.
Abstract
 
Hepatitis C virus infection and non-hodgkin lymphoma: Results of the NCI-seer multi-center
case-control study.
Engels EA, Chatterjee N, Cerhan JR, et al
Int J Cancer. 2004 Aug 10;111(1):76-80.
Abstract
 
B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: A systematic review.
Negri E, Little D, Boiocchi M, et al 
Int J Cancer. 2004 Aug 10;111(1):1-8.
Abstract
 
Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study
among Connecticut women.
Morton LM, Engels EA, Holford TR, et al
Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):425-30.
Abstract

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multi-center case-control study.
Mele A, Pulsoni A, Bianco E, et al.
Blood 2003 Apr 24;
Abstract

 

Leiomyosarcoma
 

     Journal Papers, Abstracts, and Commentaries
 
  Leiomyosarcoma of the infrarenal portion of the inferior vena cava in a cirrhotic patient
with hepatitis C.

Delis S, Triantopoulou C, Bakoyiannis A, et al  
Abdom Imaging
. 2007 Mar 27;

Abstract
 
 


HCV Main Page Main New/Newsworthy   Home Page    

HCV Oncology